219 related articles for article (PubMed ID: 28244015)
1. Bisphenol A Induces Sox2 in ER
Lillo MA; Nichols C; Seagroves TN; Miranda-Carboni GA; Krum SA
Horm Cancer; 2017 Apr; 8(2):90-99. PubMed ID: 28244015
[TBL] [Abstract][Full Text] [Related]
2. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.
Lillo MA; Nichols C; Perry C; Runke S; Krutilina R; Seagroves TN; Miranda-Carboni GA; Krum SA
J Appl Toxicol; 2017 Apr; 37(4):417-425. PubMed ID: 27581495
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
Lee GA; Hwang KA; Choi KC
Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
[TBL] [Abstract][Full Text] [Related]
4. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.
Deb P; Bhan A; Hussain I; Ansari KI; Bobzean SA; Pandita TK; Perrotti LI; Mandal SS
Gene; 2016 Sep; 590(2):234-43. PubMed ID: 27182052
[TBL] [Abstract][Full Text] [Related]
6. DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer.
Awada Z; Nasr R; Akika R; Cahais V; Cuenin C; Zhivagui M; Herceg Z; Ghantous A; Zgheib NK
Clin Epigenetics; 2019 Oct; 11(1):138. PubMed ID: 31601247
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells.
Singleton DW; Feng Y; Chen Y; Busch SJ; Lee AV; Puga A; Khan SA
Mol Cell Endocrinol; 2004 Jun; 221(1-2):47-55. PubMed ID: 15223131
[TBL] [Abstract][Full Text] [Related]
9. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
10. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.
Vivacqua A; Recchia AG; Fasanella G; Gabriele S; Carpino A; Rago V; Di Gioia ML; Leggio A; Bonofiglio D; Liguori A; Maggiolini M
Endocrine; 2003 Dec; 22(3):275-84. PubMed ID: 14709801
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits the proliferation of breast cancer cells induced by bisphenol A via targeting estrogen receptor-related pathways.
Wang T; Liu B; Guan Y; Gong M; Zhang W; Pan J; Liu Y; Liang R; Yuan Y; Ye L
Thorac Cancer; 2018 Mar; 9(3):368-375. PubMed ID: 29330934
[TBL] [Abstract][Full Text] [Related]
12. DNA damage caused by bisphenol A and estradiol through estrogenic activity.
Iso T; Watanabe T; Iwamoto T; Shimamoto A; Furuichi Y
Biol Pharm Bull; 2006 Feb; 29(2):206-10. PubMed ID: 16462019
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
14. Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines.
Ptak A; Gregoraszczuk EL
Cell Biol Toxicol; 2015 Jun; 31(3):187-97. PubMed ID: 25982407
[TBL] [Abstract][Full Text] [Related]
15. Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway.
Lee HR; Hwang KA; Park MA; Yi BR; Jeung EB; Choi KC
Int J Mol Med; 2012 May; 29(5):883-90. PubMed ID: 22307313
[TBL] [Abstract][Full Text] [Related]
16. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
[TBL] [Abstract][Full Text] [Related]
17. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
18. Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.
Hwang KA; Kang NH; Yi BR; Lee HR; Park MA; Choi KC
Int J Oncol; 2013 Feb; 42(2):733-40. PubMed ID: 23229410
[TBL] [Abstract][Full Text] [Related]
19. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption.
Ruiz TFR; Colleta SJ; Zuccari DAPC; Vilamaior PSL; Leonel ECR; Taboga SR
Life Sci; 2021 Nov; 285():120010. PubMed ID: 34606849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
